PDF(728 KB)
The distribution pattern of traditional Chinese medicine syndromes and influencing factors for primary liver cancer: An analysis of 415 cases
Zhiyao SHI, Xiaofei FAN, Yu GAO, Shaojian REN, Shiyu WU, Xixing WANG
PDF(728 KB)
PDF(728 KB)
The distribution pattern of traditional Chinese medicine syndromes and influencing factors for primary liver cancer: An analysis of 415 cases
Objective To investigate the influencing factors for traditional Chinese medicine (TCM) syndromes of primary liver cancer, and to provide a theoretical basis for the TCM syndrome differentiation and standardized treatment of liver cancer. Methods TCM syndrome differentiation was performed for 415 patients who were admitted to Shanxi Institute of Traditional Chinese Medicine and were diagnosed with primary liver cancer based on pathological or clinical examinations from January 2019 to December 2023. The chi-square test was used for comparison of categorical data between groups, and the unordered polytomous logistic regression model was used to investigate the influencing factors for TCM syndromes of liver cancer. Results The common initial symptoms of the 415 patients with primary liver cancer included pain in the liver area (31.81%), abdominal distension (25.30%), abdominal pain (15.18%), and weakness (13.98%), and the main clinical symptoms included poor appetite (70.84%), fatigue (69.16%), pain in the liver area (67.47%), poor sleep (59.04%), abdominal distension (53.01%), and constipation (52.53%). There were significant differences in TCM syndromes between patients with different sexes, courses of the disease, clinical stages, Child-Pugh classes, presence or absence of intrahepatic and extrahepatic metastasis, and presence or absence of transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (all P<0.05). The logistic regression analysis showed that male sex was a risk factor for damp-heat accumulation (odds ratio [OR]=2.036, P=0.048) and the syndrome of spleen-kidney Yang deficiency (OR=5.240, P<0.001); a course of disease of<1 year was a risk factor for damp-heat accumulation (OR=2.837, P=0.004) and syndrome of Qi stagnation and blood stasis (OR=2.317, P=0.021), but it was a protective factor against syndrome of spleen-kidney Yang deficiency (OR=0.385, P=0.005); Child-Pugh class A/B was a protective factor against liver-kidney Yin deficiency (OR=0.079, P<0.001); intrahepatic metastasis was a risk factor for liver-kidney Yin deficiency (OR=5.117, P=0.003) and syndrome of spleen-kidney Yang deficiency (OR=3.303, P=0.010); TACE was a protective factor against liver-kidney Yin deficiency (OR=0.171, P<0.001) and syndrome of spleen-kidney Yang deficiency (OR=0.138, P<0.001); radiofrequency ablation was a risk factor for damp-heat accumulation (OR=4.408, P<0.001) and liver-kidney Yin deficiency (OR=32.036, P<0.001). Conclusion Sex, course of disease, Child-Pugh class, intrahepatic metastasis, TACE, and radiofrequency ablation are the main influencing factors for TCM syndromes of liver cancer.
| 1 |
Branch of Hepatobiliary Diseases, China Association of Chinese Medicine. Guideline for traditional Chinese medicine diagnosis and treatment of primary liver cancer[J]. J Clin Hepatol, 2024, 40(5): 919-927. DOI: 10.12449/JCH240509 .
|
| 2 |
|
| 3 |
|
| 4 |
|
| 5 |
Chinese Society of Liver Cancer, Chinese Anti-Cancer Association. Chinese expert consensus on multidisciplinary treatment of liver cancer[J]. J Clin Hepatol, 2021, 37(2): 278-285. DOI: 10.3969/j.issn.1001-5256.2021.02.008 .
中国抗癌协会肝癌专业委员会. 中国肝癌多学科综合治疗专家共识[J]. 临床肝胆病杂志, 2021, 37(2): 278-285. DOI: 10.3969/j.issn.1001-5256.2021.02.008 .
|
| 6 |
孟唤男, 赵丽, 刘柳, 等. 中西医结合防治原发性肝癌研究进展[J]. 中医药学报, 2021, 49(2): 115-119. DOI: 10.19664/j.cnki.1002-2392.210049 .
|
| 7 |
黄俊辉, 钟美佐, 曹培国. 临床肿瘤诊断与治疗学[M]. 长沙: 湖南科学技术出版社, 2010: 325-329.
|
| 8 |
General Office of National Health Commission. Standard for diagnosis and treatment of primary liver cancer (2022 edition)[J]. J Clin Hepatol, 2022, 38(2): 288-303. DOI: 10.3969/j.issn.1001-5256.2022.02.009 .
国家卫生健康委办公厅. 原发性肝癌诊疗指南(2022年版)[J]. 临床肝胆病杂志, 2022, 38(2): 288-303. DOI: 10.3969/j.issn.1001-5256.2022.02.009 .
|
| 9 |
张伯礼, 吴勉华. 中医内科学[M]. 北京: 中国中医药出版社, 2017.
|
| 10 |
黄立中. 中西医结合肿瘤病学[M]. 北京: 中国中医药出版社, 2020: 231-232.
|
| 11 |
宋幸铃, 周亚娜, 李君, 等. 中医临床肝癌病例数据采集规范化研究[J]. 中西医结合肝病杂志, 2023, 33(5): 389-393. DOI: 10.3969/j.issn.1005-0264.2023.005.002 .
|
| 12 |
黎敬波, 马力. 中医临床常见症状术语规范(修订)[M]. 北京: 中国医药科技出版社, 2015.
|
| 13 |
叶丽红, 程海波, 章永红, 等. 原发性肝癌的中医病名病因探讨[J]. 时珍国医国药, 2010, 21(10): 2627-2628. DOI: 10.3969/j.issn.1008-0805.2010.10.096 .
|
| 14 |
申梅, 宋程, 赵磊, 等. 蒋益兰通过“肝脾一体, 兼调三焦”论治原发性肝癌经验[J]. 中医药导报, 2023, 29(10): 193-196. DOI: 10.13862/j.cn43-1446/r.2023.10.039 .
|
| 15 |
陈迪, 孙建光, 王伟芹. 尹常健教授治疗原发性肝癌学术思想与临证经验[J]. 中西医结合肝病杂志, 2023, 33(9): 844-847. DOI: 10.3969/j.issn.1005-0264.2023.009.018 .
|
| 16 |
陈倩倩, 芮法娟, 倪文婧, 等. 原发性肝癌的流行病学及其危险因素研究进展[J]. 中国全科医学, 2024, 27(6): 637-642. DOI: 10.12114/j.issn.1007-9572.2023.0479 .
|
| 17 |
|
| 18 |
|
| 19 |
|
| 20 |
艾望, 夏玉坤, 王秀萍, 等. 原发性肝癌中医药治疗研究进展[J]. 辽宁中医药大学学报, 2018, 20(3): 133-136. DOI: 10.13194/j.issn.1673-842x.2018.03.039 .
|
| 21 |
|
| 22 |
周灏, 刘丽丽, 施美, 等. 徐经世国医大师扶正祛邪治疗肝癌经验总结[J]. 中西医结合肝病杂志, 2022, 32(2): 106-109. DOI: 10.3969/j.issn.1005-0264.2022.02.003 .
|
| 23 |
邹毅, 刘寨东, 刘宗凯, 等. 齐元富基于体阴用阳治疗原发性肝癌介入栓塞后综合征经验[J]. 中医药导报, 2023, 29(7): 178-180, 198. DOI: 10.13862/j.cn43-1446/r.2023.07.035 .
|
| 24 |
何世仪, 钱峻, 霍介格. 徐荷芬治疗原发性肝癌的临床经验[J]. 时珍国医国药, 2017, 28(7): 1736-1737. DOI: 10.3969/j.issn.1008-0805.2017.07.073 .
|
| 25 |
谢林虎, 王凤玲, 刘建军. 原发性肝癌介入联合免疫治疗的研究进展[J]. 长春中医药大学学报, 2024, 40(5): 586-590. DOI: 10.13463/j.cnki.cczyy.2024.05.026 .
|
| 26 |
卿小松, 王学文, 罗国松, 等. 载药微球联合TACE治疗原发性肝癌患者的效果观察[J]. 临床误诊误治, 2024, 37(12): 26-30. DOI: 10.3969/j.issn.1002-3429.2024.12.006 .
|
| 27 |
侯宝松, 刘霞, 王海峰, 等. 逍遥方合大黄虫方加减联合肝动脉化疗栓塞术对原发性肝癌肝郁脾虚证患者免疫功能和生活质量的影响[J]. 河北中医, 2020, 42(9): 1346-1350, 1368. DOI: 10.3969/j.issn.1002-2619.2020.09.016 .
|
| 28 |
崔军辉. 疏肝健脾汤干预肝癌化疗栓塞术后胃肠反应30例疗效观察[J]. 国医论坛, 2019, 34(2): 36-37. DOI: 10.13913/j.cnki.41-1110/r.2019.02.017 .
|
| 29 |
韩明, 周军, 魏海梁, 等. 肝癌经导管动脉化疗栓塞术后栓塞综合征中医治疗进展[J]. 中国中医药信息杂志, 2021, 28(11): 138-142. DOI: 10.19879/j.cnki.1005-5304.202104041 .
|
| 30 |
薛丽娟, 管云, 张玲, 等. 中医穴位贴敷用于肝癌介入术后便秘中的临床效果观察[J/CD]. 实用妇科内分泌电子杂志, 2020, 7(28): 183-184. DOI: 10.16484/j.cnki.issn2095-8803.2020.28.121 .
|
| 31 |
吉晶, 魏国利, 尹国文, 等. 耳穴压豆治疗原发性肝癌TACE术后不良反应临床观察[J]. 西部中医药, 2020, 33(10): 124-126.DOI: 10.12174/j.issn.1004-6852.2020.10.34 .
|
石智尧负责资料收集及分析,撰写论文;凡晓菲、任少键、武时瑜参与数据收集,修改论文;高宇、王晞星负责课题设计,指导撰写论文并最后定稿。
/
| 〈 |
|
〉 |